Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Savara Inc Director's Dealing 2023

Jun 27, 2023

32709_dirs_2023-06-27_f14a7814-5129-45b2-b7c9-7c4e0f3ee868.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Savara Inc (SVRA)
CIK: 0001160308
Period of Report: 2023-06-26

Reporting Person: Pratt Raymond Dennis (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-06-26 Common Stock P 6500 $2.93 Acquired 160000 Direct